SAUMYA ANTONY: Open Payments
NPI 1801481288 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 26 payments from 11 companies in 2025. Trend: 2023 $4,278 · 2024 $2,844 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $127 |
| Janssen Pharmaceuticals, Inc | 5 | $121 |
| Neurocrine BioSciences, Inc. | 4 | $83 |
| ABBVIE INC. | 2 | $54 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $29 |
| OWP Pharmaceuticals, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $18 |
Products named: CAPLYTA, SPRAVATO, INGREZZA, VRAYLAR, REXULTI, Auvelity, INVEGA SUSTENNA, Subvenite.
Industry payments across TX — which companies pay providers there.
